Revolution Medicines

Revolution Medicines is a U.S.-based company dedicated to developing innovative, targeted medicines for patients with RAS-addicted cancers. The company is pioneering a portfolio of RAS(ON) inhibitors using its revolutionary tri-complex inhibitor platform, with multiple investigational therapies currently in clinical trials and a robust preclinical pipeline targeting a spectrum of RAS mutations.